|
|||||
|
|
A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer |
|
| Authors: | Gordana Vlahovic Kellen L. Meadows Ace J. Hatch Jingquan Jia Andrew B. Nixon Hope E. Uronis Michael A. Morse M. Angelica Selim Jeffrey Crawford Richard F. Riedel S. Yousuf Zafar Leigh A. Howard Margot O'Neill Jennifer J. Meadows Sherri T. Haley Christy C. Arrowood Christel Rushing Herbert Pang Herbert I. Hurwitz |
| Affiliation: | 1. Duke Cancer Institute, Durham, North Carolina, USA;2. Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA;3. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA |
| Abstract: | |
| Keywords: | Ganitumab Everolimus Panitumumab Phase I Advanced cancer |